P18 Patient Preferences for Attributes of a Multi-Cancer Early Detection Test: A Discrete Choice Experiment (DCE) Quantitative Pilot Study

Early cancer detection and intervention can significantly improve patient outcomes and reduce mortality rates. Evidence shows that emerging blood-based multi-cancer early detection (MCED) tests can detect a variety of cancer types across stages and provide a predicted cancer signal origin with high specificity. However, little is known about patients’ preferences for MCED tests. This study aimed to quantify preferences for attributes of blood-based MCED tests among the US general population aged 50-80 years.